321 related articles for article (PubMed ID: 29741149)
1. Case Report: Probable Case of Spontaneous Encephalopathy Due to Loiasis and Dramatic Reduction of
Arrey-Agbor DB; Nana-Djeunga HC; Mogoung-Wafo AE; Mafo M; Danwe C; Kamgno J
Am J Trop Med Hyg; 2018 Jul; 99(1):112-115. PubMed ID: 29741149
[TBL] [Abstract][Full Text] [Related]
2. Encephalopathy in a patient with loiasis treated with albendazole: A case report.
Volpicelli L; De Angelis M; Morano A; Biliotti E; Franchi C; Gabrielli S; Mattiucci S; Di Bonaventura C; Taliani G
Parasitol Int; 2020 Apr; 75():102006. PubMed ID: 31676328
[TBL] [Abstract][Full Text] [Related]
3. [Secondary effects of the treatment of hypermicrofilaremic loiasis using ivermectin].
Ducorps M; Gardon-Wendel N; Ranque S; Ndong W; Boussinesq M; Gardon J; Schneider D; Chippaux JP
Bull Soc Pathol Exot; 1995; 88(3):105-12. PubMed ID: 8555762
[TBL] [Abstract][Full Text] [Related]
4. Loiasis in US Traveler Returning from Bioko Island, Equatorial Guinea, 2016.
Priest DH; Nutman TB
Emerg Infect Dis; 2017 Jan; 23(1):160-162. PubMed ID: 27983940
[TBL] [Abstract][Full Text] [Related]
5. Repurposing auranofin as a lead candidate for treatment of lymphatic filariasis and onchocerciasis.
Bulman CA; Bidlow CM; Lustigman S; Cho-Ngwa F; Williams D; Rascón AA; Tricoche N; Samje M; Bell A; Suzuki B; Lim KC; Supakorndej N; Supakorndej P; Wolfe AR; Knudsen GM; Chen S; Wilson C; Ang KH; Arkin M; Gut J; Franklin C; Marcellino C; McKerrow JH; Debnath A; Sakanari JA
PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003534. PubMed ID: 25700363
[TBL] [Abstract][Full Text] [Related]
6. Loa loa-does it deserve to be neglected?
Metzger WG; Mordmüller B
Lancet Infect Dis; 2014 Apr; 14(4):353-7. PubMed ID: 24332895
[TBL] [Abstract][Full Text] [Related]
7. Comparison of different drug regimens for the treatment of loiasis-A TropNet retrospective study.
Gobbi F; Bottieau E; Bouchaud O; Buonfrate D; Salvador F; Rojo-Marcos G; Rodari P; Clerinx J; Treviño B; Herrera-Ávila JP; Neumayr A; Calleri G; Angheben A; Rothe C; Zammarchi L; Guerriero M; Bisoffi Z
PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006917. PubMed ID: 30383753
[TBL] [Abstract][Full Text] [Related]
8. Effects of a 3-day regimen of albendazole (800 mg daily) on Loa loa microfilaraemia.
Tsague-Dongmo L; Kamgno J; Pion SD; Moyou-Somo R; Boussinesq M
Ann Trop Med Parasitol; 2002 Oct; 96(7):707-15. PubMed ID: 12537632
[TBL] [Abstract][Full Text] [Related]
9. Effect of a single dose (600 mg) of albendazole on Loa loa microfilaraemia.
Kamgno J; Boussinesq M
Parasite; 2002 Mar; 9(1):59-63. PubMed ID: 11938697
[TBL] [Abstract][Full Text] [Related]
10. Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns.
Cano J; Basáñez MG; O'Hanlon SJ; Tekle AH; Wanji S; Zouré HG; Rebollo MP; Pullan RL
Parasit Vectors; 2018 Jan; 11(1):70. PubMed ID: 29382363
[TBL] [Abstract][Full Text] [Related]
11. Identification and Validation of Loa loa Microfilaria-Specific Biomarkers: a Rational Design Approach Using Proteomics and Novel Immunoassays.
Drame PM; Meng Z; Bennuru S; Herrick JA; Veenstra TD; Nutman TB
mBio; 2016 Feb; 7(1):e02132-15. PubMed ID: 26884435
[TBL] [Abstract][Full Text] [Related]
12. [Loa loa filariasis in Italy: review of the literature with a clinical report].
Sgrelli A; De Socio GV; Papili R; D'Annibale ML; Baldelli F
Infez Med; 2011 Sep; 19(3):147-51. PubMed ID: 22037434
[TBL] [Abstract][Full Text] [Related]
13. In Southern Nigeria
Emukah E; Rakers LJ; Kahansim B; Miri ES; Nwoke BEB; Griswold E; Saka Y; Anagbogu I; Davies E; Ityonzughul C; D'Ambrosio M; Bakalar M; Fletcher DA; Nutman T; Kamgno J; Richards FO
Am J Trop Med Hyg; 2018 Jul; 99(1):116-123. PubMed ID: 29761763
[TBL] [Abstract][Full Text] [Related]
14. Co-endemicity of loiasis and onchocerciasis in rain forest communities in southwestern Nigeria.
Ojurongbe O; Akindele AA; Adeleke MA; Oyedeji MO; Adedokun SA; Ojo JF; Akinleye CA; Bolaji OS; Adefioye OA; Adeyeba OA
PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003633. PubMed ID: 25812086
[TBL] [Abstract][Full Text] [Related]
15. A Test-and-Not-Treat Strategy for Onchocerciasis in Loa loa-Endemic Areas.
Kamgno J; Pion SD; Chesnais CB; Bakalar MH; D'Ambrosio MV; Mackenzie CD; Nana-Djeunga HC; Gounoue-Kamkumo R; Njitchouang GR; Nwane P; Tchatchueng-Mbouga JB; Wanji S; Stolk WA; Fletcher DA; Klion AD; Nutman TB; Boussinesq M
N Engl J Med; 2017 Nov; 377(21):2044-2052. PubMed ID: 29116890
[TBL] [Abstract][Full Text] [Related]
16. Ivermectin treatment of Loa loa hyper-microfilaraemic baboons (Papio anubis): Assessment of microfilarial load reduction, haematological and biochemical parameters and histopathological changes following treatment.
Wanji S; Eyong EJ; Tendongfor N; Ngwa CJ; Esuka EN; Kengne-Ouafo AJ; Datchoua-Poutcheu FR; Enyong P; Agnew D; Eversole RR; Hopkins A; Mackenzie CD
PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005576. PubMed ID: 28686693
[TBL] [Abstract][Full Text] [Related]
17. Effect of Two or Six Doses 800 mg of Albendazole Every Two Months on Loa loa Microfilaraemia: A Double Blind, Randomized, Placebo-Controlled Trial.
Kamgno J; Nguipdop-Djomo P; Gounoue R; Téjiokem M; Kuesel AC
PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004492. PubMed ID: 26967331
[TBL] [Abstract][Full Text] [Related]
18. Implications for annual retesting after a test-and-not-treat strategy for onchocerciasis elimination in areas co-endemic with Loa loa infection: an observational cohort study.
Pion SD; Nana-Djeunga H; Niamsi-Emalio Y; Chesnais CB; Deléglise H; Mackenzie C; Stolk W; Fletcher DA; Klion AD; Nutman TB; Boussinesq M; Kamgno J
Lancet Infect Dis; 2020 Jan; 20(1):102-109. PubMed ID: 31676244
[TBL] [Abstract][Full Text] [Related]
19. Loa loa vectors Chrysops spp.: perspectives on research, distribution, bionomics, and implications for elimination of lymphatic filariasis and onchocerciasis.
Kelly-Hope L; Paulo R; Thomas B; Brito M; Unnasch TR; Molyneux D
Parasit Vectors; 2017 Apr; 10(1):172. PubMed ID: 28381279
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and intensity of Loa loa infection over twenty-three years in three communities of the Mbalmayo health district (Central Cameroon).
Mogoung-Wafo AE; Nana-Djeunga HC; Domche A; Fossuo-Thotchum F; Bopda J; Mbickmen-Tchana S; Djomo-Kamga H; Kamgno J
BMC Infect Dis; 2019 Feb; 19(1):146. PubMed ID: 30760228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
